Tang, Bor Luen

A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease

Yeo-Teh, N. S. L., & Tang, B. L. (2023) · Science and Engineering Ethics

Alzheimer's disease research and treatmentsEthics in Clinical Research

Cited by 28

Could sirtuin activities modify ALS onset and progression?

Tang, B. L. (2017) · Cellular and Molecular Neurobiology

Amyotrophic Lateral Sclerosis ResearchSirtuins and Resveratrol in Medicine

Cited by 24

Widespread γ-secretase activity in the cell, but do we need it at the mitochondria?

Teng, F. Y. H., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications

Alzheimer's disease research and treatmentsMitochondrial Function and Pathology

Cited by 21

Linking primary cilia defects to the 'Big 3' neurodegenerative diseases - causal, consequential, or correlative?

Hor, C. H. H., & Tang, B. L. (2026) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund

Genetic and Kidney Cyst DiseasesCystic Fibrosis Research Advances

Cited by 0